Fundz

Sanyou Biopharmaceuticals Completes Series B Financing And Secures Its Leading Role In Innovative Antibody Drug Discovery

Jun 26, 2021

Round Type

Series B

ShanghaiBiotechnology

Description

Sanyou Biopharmaceutical (Shanghai) Co., Ltd. (hereafter referred to as "Sanyou Bio" or "the Company"), a leading company in innovative antibody drug discovery, announced the closing of series B financing. This financing round was co-led by LH Ventures and Montesy Investment, and followed by Grand Mount Capital and Seeking Capital (an existing investor). After this round of financing, Zhiyin Lan, venture partner of LH Ventures, will join the Board of Directors of Sanyou Bio

Quick answer

SanyouBio raised an undisclosed amount in a Series B round, dated June 26, 2021. SanyouBio is based in Shanghai, China.

How much did SanyouBio raise?
SanyouBio raised an undisclosed amount in a Series B round on June 26, 2021.
What does SanyouBio do?
Sanyou Biopharmaceuticals Co., Ltd. is a world-leading high-tech biotechnology enterprise focusing on R&D and services of innovative biologic drugs.
Where is SanyouBio based and how big is it?
SanyouBio is based in Shanghai, China. Fundz records about 300 employees.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as SanyouBio that raised within 45 days of this round, from Fundz verified event records.

  • Sydnexis raised $45M (Series B) on August 10, 2021.
  • BioProtonics raised $1M on August 10, 2021.
  • Appili Therapeutics Inc. raised $3.5M (Seed) on August 9, 2021.
  • KaliVir Immunotherapeutics raised $8.7M (Series A) on August 9, 2021.
  • Navrogen, Inc. raised $3M (Seed) on August 9, 2021.
  • Meadowhawk Biolabs raised $9.3M on August 9, 2021.

Who to call at SanyouBio, and when

A new round usually means SanyouBio is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day SanyouBio raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at SanyouBio, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at SanyouBio. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

SanyouBio

Location

Shanghai, China

About

Sanyou Biopharmaceuticals Co., Ltd. is a world-leading high-tech biotechnology enterprise focusing on R&D and services of innovative biologic drugs. The company has built a 4C business model integrating differentiated CRO, integrated CDO, innovative CPO, and characteristic CRS. Their mission is to simplify the R&D process for innovative biologics. Sanyou has established an advanced R&D laboratory and has a professional team with many members holding Ph.D. or master's degrees.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment SanyouBio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for SanyouBio's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

SanyouBio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.